Velan Capital Investment Management LP CRBP — CORBUS PHARMACEUTICALS HLDGS

Ownership history in Velan Capital Investment Management LP  ·  8 quarters on record

AI Ownership Summary

Velan Capital Investment Management LP reported CORBUS PHARMACEUTICALS HLDGS (CRBP) in 8 quarterly 13F filings from 2024 Q3 through 2026 Q2. Peak portfolio weight reached 0.96% in 2024 Q3. The latest visible filing shows CRBP at 0.15% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this CRBP ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Velan Capital Investment Management LP's position in CORBUS PHARMACEUTICALS HLDGS, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

CRBP was reported at 0.15% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.96% in 2024 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q3 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Velan Capital Investment Management LP held CRBP — position size vs. price
% of Fund (quarterly)    CRBP price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 8 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 UNCHANGED — — — 26,000 — 0% 0.15% $244K 2026-08-14 $10.09
2026 Q1 ADDED — — — 26,000 +13,000 +100.0% 0.15% $244K 2026-05-15 $11.03
2025 Q4 REDUCED 78.7% +15.4% ❌ 13,000 -48,000 -78.7% 0.06% $106K 2026-02-13 $7.56
2025 Q3 ADDED — — — 61,000 +2,000 +3.4% 0.72% $772K 2025-11-14 $11.07
2025 Q2 UNCHANGED — — — 59,000 — 0% 0.40% $407.1M 2025-08-14 $9.63
2025 Q1 ADDED — — — 59,000 +2,300 +4.1% 0.32% $313.3M 2025-05-15 $7.21
2024 Q4 ADDED — — — 56,700 +6,700 +13.4% 0.58% $669.1M 2025-02-14 $8.51
2024 Q3 INITIATED — — — 50,000 — — 0.96% $1.0M 2024-11-14 $17.55

FAQ About Velan Capital Investment Management LP and CRBP

These are the practical questions this page is built to answer before you even open the full history table.

How long has Velan Capital Investment Management LP reported owning CRBP?

Velan Capital Investment Management LP reported CRBP across 8 quarterly 13F filings, from 2024 Q3 through 2026 Q2.

What was the largest reported CRBP position in Velan Capital Investment Management LP's portfolio?

The largest reported portfolio weight for CRBP was 0.96% in 2024 Q3.

What is the latest reported CRBP position on this page?

The most recent filing on this page is 2026 Q2, when Velan Capital Investment Management LP reported 26,000 shares, equal to 0.15% of portfolio, with an estimated market value of $244K.

What does the chart on this CRBP ownership page compare?

The chart compares Velan Capital Investment Management LP's quarterly CRBP portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Velan Capital Investment Management LP time their CRBP position?

Based on 13F filing dates vs. subsequent CRBP price moves, Velan Capital Investment Management LP correctly timed 1 out of 6 reported position changes (17%). The annualised alpha on CRBP relative to SPY over the holding period was -38.3%.

← Back to Velan Capital Investment Management LP Holdings